The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review
Author:
Publisher
Informa UK Limited
Subject
Immunology,General Medicine,Immunology and Allergy,Rheumatology
Link
http://www.tandfonline.com/doi/pdf/10.1080/03009740701607067
Reference40 articles.
1. North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care
2. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
3. Network meta-analysis for indirect treatment comparisons
4. Combination of direct and indirect evidence in mixed treatment comparisons
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Les poussées seulement transitoires des rhumatismes inflammatoires chroniques ne devraient plus être scotomisées;Revue du Rhumatisme;2023-12
2. Transient flares (attacks) of inflammatory arthritis should be more considered;Joint Bone Spine;2023-05
3. Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis;Rheumatology;2022-10-03
4. An Integrative Pharmacology Model for Decoding the Underlying Therapeutic Mechanisms of Ermiao Powder for Rheumatoid Arthritis;Frontiers in Pharmacology;2022-02-23
5. Personalized treatment selection in routine care: Integrating machine learning and statistical algorithms to recommend cognitive behavioral or psychodynamic therapy;Psychotherapy Research;2020-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3